TXG - 10x Genomics GAAP EPS of -$0.38 misses by $0.07 revenue of $114.5M beats by $1.17M
10x Genomics press release (NASDAQ:TXG): Q1 GAAP EPS of -$0.38 misses by $0.07. Revenue of $114.5M (+8.2% Y/Y) beats by $1.17M. 10x Genomics is maintaining its full year 2022 revenue guidance of $600 million to $630 million, representing 22% to 28% growth over full year 2021 revenue.
For further details see:
10x Genomics GAAP EPS of -$0.38 misses by $0.07, revenue of $114.5M beats by $1.17M